Opening book details…
About this Medicine article
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC) by Awad, Mark M.; Chu, Quincy S-C; Gandhi, Leena; Stephenson, Joe J.; Govindan, Ramaswamy; Bradford, Daniel S.; Bonomi, Philip D.; Ellison, David M.; Eaton, Keith D.; Fritsch, Holger; Munzert, Gerd; Johnson, Bruce E.; Socinski, Mark A. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Awad, Mark M.; Chu, Quincy S-C; Gandhi, Leena; Stephenson, Joe J.; Govindan, Ramaswamy; Bradford, Daniel S.; Bonomi, Philip D.; Ellison, David M.; Eaton, Keith D.; Fritsch, Holger; Munzert, Gerd; Johnson, Bruce E.; Socinski, Mark A.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0169-5002)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)